PPARG and Hepatic fibrosis: Interestingly, a recent study reported that PPAR-γ inhibited hepatic stellate cells driven angiogenesis via the suppression of PDGF-β receptor expression and suggested that PPAR-γ could be a molecular target for preventing vascular remolding in hepatic fibrosis (Zhang F. et al., 2014).